Agile_Logo-color on white.jpg
Agile Therapeutics Announces Closing of $7.5 Million Public Offering
25 mai 2023 16h05 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., May 25, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
22 mai 2023 20h00 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., May 22, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its...
Agile_Logo-color on white.jpg
Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update
11 mai 2023 16h05 HE | Agile Therapeutics, Inc.
Twirla Delivers Single-Quarter Records for Retail and Non-Retail Demand; Both Channels Up 20% in First Quarter 2023 vs Fourth Quarter 2022 Total OPEX down 8% in First Quarter 2023 vs Fourth...
Agile_Logo-color on white.jpg
Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023
08 mai 2023 08h00 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2023 financial results after the...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
28 avr. 2023 08h01 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla®...
Agile_Logo-color on white.jpg
Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
26 avr. 2023 09h01 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the Listing...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces 1-For-50 Reverse Stock Split
10 avr. 2023 16h30 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., April 10, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women's healthcare company, today announced that its board of directors approved a 1-for-50...
Agile_Logo-color on white.jpg
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update
22 mars 2023 16h05 HE | Agile Therapeutics, Inc.
Fourth Quarter 2022 Net Revenue Increased 33% from Third Quarter 2022 While GAAP Quarter-Over-Quarter OPEX Decreased 55% and Non-GAAP OPEX Remained Unchanged Twirla Demand and Factory Sales...
Agile_Logo-color on white.jpg
Agile Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on Wednesday, March 22, 2023
21 mars 2023 09h05 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 financial...
Agile_Logo-color on white.jpg
Agile Therapeutics Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement
27 févr. 2023 08h31 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received written...